Los puntos clave no están disponibles para este artículo en este momento.
Analyses of at-risk cognitively normal populations suggest that we can reliably measure the first signs of cognitive decline with the ADCS-PACC. These analyses also suggest the feasibility of secondary prevention trials.
Donohue et al. (Mon,) studied this question.